89 related articles for article (PubMed ID: 24108119)
1. High-content analysis to leverage a robust phenotypic profiling approach to vascular modulation.
Isherwood BJ; Walls RE; Roberts ME; Houslay TM; Brave SR; Barry ST; Carragher NO
J Biomol Screen; 2013 Dec; 18(10):1246-59. PubMed ID: 24108119
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic characterization of a kinetic in vitro human co-culture angiogenesis model using clinically relevant compounds.
Wolfe A; O'Clair B; Groppi VE; McEwen DP
J Biomol Screen; 2013 Dec; 18(10):1234-45. PubMed ID: 24019254
[TBL] [Abstract][Full Text] [Related]
3. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
Evensen L; Micklem DR; Link W; Lorens JB
Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
[TBL] [Abstract][Full Text] [Related]
4. Identification of Angiogenesis Inhibitors Using a Co-culture Cell Model in a High-Content and High-Throughput Screening Platform.
Li S; Hsu CW; Sakamuru S; Zou C; Huang R; Xia M
SLAS Technol; 2018 Jun; 23(3):217-225. PubMed ID: 28922619
[TBL] [Abstract][Full Text] [Related]
5. Image-based high-throughput screening for inhibitors of angiogenesis.
Evensen L; Link W; Lorens JB
Methods Mol Biol; 2013; 931():139-51. PubMed ID: 23027002
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy.
Carlson C; Koonce C; Aoyama N; Einhorn S; Fiene S; Thompson A; Swanson B; Anson B; Kattman S
J Biomol Screen; 2013 Dec; 18(10):1203-11. PubMed ID: 24071917
[TBL] [Abstract][Full Text] [Related]
7. Contextual compound screening for improved therapeutic discovery.
Evensen L; Odlo K; Micklem DR; Littlewood-Evans A; Wood J; Kuzniewski C; Altmann KH; Hansen TV; Lorens JB
Chembiochem; 2013 Dec; 14(18):2512-8. PubMed ID: 24222525
[TBL] [Abstract][Full Text] [Related]
8. Benchmarking of multivariate similarity measures for high-content screening fingerprints in phenotypic drug discovery.
Reisen F; Zhang X; Gabriel D; Selzer P
J Biomol Screen; 2013 Dec; 18(10):1284-97. PubMed ID: 24045583
[TBL] [Abstract][Full Text] [Related]
9. Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish.
Camus S; Quevedo C; Menéndez S; Paramonov I; Stouten PF; Janssen RA; Rueb S; He S; Snaar-Jagalska BE; Laricchia-Robbio L; Izpisua Belmonte JC
Oncogene; 2012 Sep; 31(39):4333-42. PubMed ID: 22179836
[TBL] [Abstract][Full Text] [Related]
10. Differentiation and visualization of diverse cellular phenotypic responses in primary high-content screening.
Kümmel A; Selzer P; Siebert D; Schmidt I; Reinhardt J; Götte M; Ibig-Rehm Y; Parker CN; Gabriel D
J Biomol Screen; 2012 Jul; 17(6):843-9. PubMed ID: 22396475
[TBL] [Abstract][Full Text] [Related]
11. FRET-based calcium imaging: a tool for high-throughput/content phenotypic drug screening in Alzheimer disease.
Honarnejad K; Kirsch AK; Daschner A; Szybinska A; Kuznicki J; Herms J
J Biomol Screen; 2013 Dec; 18(10):1309-20. PubMed ID: 24221842
[TBL] [Abstract][Full Text] [Related]
12. Highly multiplexed phenotypic imaging for cell proliferation studies.
Cappella P; Gasparri F
J Biomol Screen; 2014 Jan; 19(1):145-57. PubMed ID: 23896684
[TBL] [Abstract][Full Text] [Related]
13. A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: from in silico screening to cyclodextrin formulation.
Radi M; Evensen L; Dreassi E; Zamperini C; Caporicci M; Falchi F; Musumeci F; Schenone S; Lorens JB; Botta M
Bioorg Med Chem Lett; 2012 Sep; 22(17):5579-83. PubMed ID: 22853993
[TBL] [Abstract][Full Text] [Related]
14. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
Tran TC; Sneed B; Haider J; Blavo D; White A; Aiyejorun T; Baranowski TC; Rubinstein AL; Doan TN; Dingledine R; Sandberg EM
Cancer Res; 2007 Dec; 67(23):11386-92. PubMed ID: 18056466
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
16. High content screening: seeing is believing.
Zanella F; Lorens JB; Link W
Trends Biotechnol; 2010 May; 28(5):237-45. PubMed ID: 20346526
[TBL] [Abstract][Full Text] [Related]
17. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
Li X; Wang X; Ye H; Peng A; Chen L
Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
[TBL] [Abstract][Full Text] [Related]
18. Enrichment analysis for discovering biological associations in phenotypic screens.
Polyakov VR; Moorcroft ND; Drawid A
J Chem Inf Model; 2014 Feb; 54(2):377-86. PubMed ID: 24437550
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
20. Cell-based fuzzy metrics enhance high-content screening (HCS) assay robustness.
Azegrouz H; Karemore G; Torres A; Alaíz CM; Gonzalez AM; Nevado P; Salmerón A; Pellinen T; del Pozo MA; Dorronsoro JR; Montoya MC
J Biomol Screen; 2013 Dec; 18(10):1270-83. PubMed ID: 24045580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
